Literature DB >> 11404367

Gelatinase B functions as regulator and effector in leukocyte biology.

G Opdenakker1, P E Van den Steen, B Dubois, I Nelissen, E Van Coillie, S Masure, P Proost, J Van Damme.   

Abstract

Matrix metalloproteinases (MMPs) form a family of enzymes with major actions in the remodeling of extracellular matrix (ECM) components. Gelatinase B (MMP-9) is the most complex family member in terms of domain structure and regulation of its activity. Gelatinase B activity is under strict control at various levels: transcription of the gene by cytokines and cellular interactions; activation of the pro-enzyme by a cascade of enzymes comprising serine proteases and other MMPs; and regulation by specific tissue inhibitors of MMPs (TIMPs) or by unspecific inhibitors, such as alpha2-macroglobulin. Thus, remodeling ECM is the result of the local protease load, i.e., the net balance between enzymes and inhibitors. Glycosylation has a limited effect on the net activity of gelatinase B, and in contrast to the all-or-none effect of enzyme activation or inhibition, it results in a higher-level, fine-tuning effect on the ECM catalysis by proteases in mammalian species. Fast degranulation of considerable amounts of intracellularly stored gelatinase B from neutrophils, induced by various types of chemotactic factors, is another level of control of activity. Neutrophils are first-line defense leukocytes and do not produce gelatinase A or TIMP. Thus, neutrophils contrast sharply with mononuclear leukocytes, which produce gelatinase A constitutively, synthesize gelatinase B de novo after adequate triggering, and overproduce TIMP-1. Gelatinase B is also endowed with functions other than cleaving the ECM. It has been shown to generate autoimmune neo-epitopes and to activate pro-IL-1beta into active IL-1beta. Gelatinase B ablation in the mouse leads to altered bone remodeling and subfertility, results in resistance to several induced inflammatory or autoimmune pathologies, and indicates that the enzyme plays a crucial role in development and angiogenesis. The major human neutrophil chemoattractant, IL-8, stimulates fast degranulation of gelatinase B from neutrophils. Gelatinase B is also found to function as a regulator of neutrophil biology and to truncate IL-8 at the amino terminus into a tenfold more potent chemokine, resulting in an important positive feedback loop for neutrophil activation and chemotaxis. The CXC chemokines GRO-alpha, CTAP-III, and PF-4 are degraded by gelatinase B, whereas the CC chemokines MCP-2 and RANTES are not cleaved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404367

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  147 in total

1.  Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.

Authors:  Jennifer Vandooren; Benjamin Born; Inna Solomonov; Ewa Zajac; Radka Saldova; Michael Senske; Estefanía Ugarte-Berzal; Erik Martens; Philippe E Van den Steen; Jo Van Damme; Angeles Garcia-Pardo; Matheus Froeyen; Elena I Deryugina; James P Quigley; Søren K Moestrup; Pauline M Rudd; Irit Sagi; Ghislain Opdenakker
Journal:  Biochem J       Date:  2015-01-15       Impact factor: 3.857

Review 2.  Neutrophils in periodontal inflammation.

Authors:  David A Scott; Jennifer Krauss
Journal:  Front Oral Biol       Date:  2011-11-11

3.  Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection.

Authors:  Jiehao Zhou; Stephen A Stohlman; Roscoe Atkinson; David R Hinton; Norman W Marten
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

4.  Anaplasma phagocytophilum infection induces protracted neutrophil degranulation.

Authors:  Kyoung-seong Choi; Dennis J Grab; J Stephen Dumler
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

5.  Immobilizing reporters for molecular imaging of the extracellular microenvironment in living animals.

Authors:  Zuyong Xia; Yun Xing; Jongho Jeon; Young-Pil Kim; Jessica Gall; Anca Dragulescu-Andrasi; Sanjiv S Gambhir; Jianghong Rao
Journal:  ACS Chem Biol       Date:  2011-08-23       Impact factor: 5.100

6.  Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9.

Authors:  Elzbieta Kolaczkowska; Barbara Plytycz; Bernd Arnold; Helene Piccard; Ghislain Opdenakker
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

Review 7.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

8.  Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.

Authors:  Didier D Cataldo; Kurt G Tournoy; Karim Vermaelen; Carine Munaut; Jean-Michel Foidart; Renaud Louis; Agnès Noël; Romain A Pauwels
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation.

Authors:  Milan Chromek; Kjell Tullus; Joachim Lundahl; Annelie Brauner
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 10.  Matrix metalloproteinase-9 and autoimmune diseases.

Authors:  Maya Ram; Yaniv Sherer; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.